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Limits of aerobic metabolism in 
cancer cells
Jorge Fernandez-de-Cossio-Diaz1 & Alexei Vazquez  2,3
Cancer cells exhibit high rates of glycolysis and glutaminolysis. Glycolysis can provide energy and 
glutaminolysis can provide carbon for anaplerosis and reductive carboxylation to citrate. However, all 
these metabolic requirements could be in principle satisfied from glucose. Here we investigate why 
cancer cells do not satisfy their metabolic demands using aerobic biosynthesis from glucose. Based on 
the typical composition of a mammalian cell we quantify the energy demand and the OxPhos burden 
of cell biosynthesis from glucose. Our calculation demonstrates that aerobic growth from glucose 
is feasible up to a minimum doubling time that is proportional to the OxPhos burden and inversely 
proportional to the mitochondria OxPhos capacity. To grow faster cancer cells must activate aerobic 
glycolysis for energy generation and uncouple NADH generation from biosynthesis. To uncouple 
biosynthesis from NADH generation cancer cells can synthesize lipids from carbon sources that do 
not produce NADH in their catabolism, including acetate and the amino acids glutamate, glutamine, 
phenylalanine and tyrosine. Finally, we show that cancer cell lines have an OxPhos capacity that is 
insufficient to support aerobic biosynthesis from glucose. We conclude that selection for high rate 
of biosynthesis implies a selection for aerobic glycolysis and uncoupling biosynthesis from NADH 
generation.
Cancer cells exhibit high rates of glucose fermentation to lactate even when growing in aerobic conditions, a phe-
notype known as aerobic glycolysis or the Warburg effect. The Warburg effect is accompanied by other metabolic 
alterations, particularly increased glutamine utilization1–4 and reductive carboxylation of glutamine to the lipid 
precursor AcCoA5. More recently, acetate has been shown to be another important source of AcCoA in cancer 
cells6–9 and its contribution increases under oxygen limitation6.
Given that fermentation of glucose is the default pathway under anaerobic growth, Warburg originally thought 
that aerobic glycolysis should be rooted on mitochondrial defects10,11. However, cells from healthy mammalian 
tissues also manifest aerobic glycolysis and glutaminolysis during fast growth12–15. Furthermore, aerobic glycolysis 
is observed with concomitant high rates of respiratory metabolism in cancer15 and muscle16 cells.
Quantitative models of cell metabolism have been used to investigate the cause of aerobic glycolysis and 
related metabolic phenotypes. The postulation of a maximum oxygen consumption rate results in model predic-
tions mimicking aerobic glycolysis in yeast17 and the Warburg effect (unpublished data). However, under aero-
bic conditions, further increase of the oxygenation level does not abrogate aerobic glycolysis16,18. Simulations of 
genome scale models of mammalian cell metabolism also predict the utilization of glutamine at high proliferation 
rates19,20. However, we do not understand what aspects of the model are responsible for that prediction.
Results
OxPhos burden of aerobic growth from glucose. To gain a better understanding of cell metabolism 
as a function of the growth metabolic demand we performed a back-of-the-envelope calculation focusing on 
the major biomass components of mammalian cells. The dry weight of mammalian cells is mostly composed of 
protein, lipids and polysaccharides (Table 1). Based on this composition we can estimate the biosynthetic demand 
for precursor metabolites and the energy that is necessary to duplicate the cell content. The duplication of a typ-
ical mammalian cell requires about 1.1 mol/L of amino acids for protein synthesis, 1.2 mol/L of AcCoA for lipid 
synthesis and an energy demand of bdemand = 6.0 mol/L of ATP (Table 1).
The synthesis of biomass precursors from glucose makes use of different dehydrogenases producing/con-
suming NADH (Fig. 1). The synthesis of some amino acids involves transamination coupled with glutamate 
to α-ketoglutarate conversion. α-ketoglutarate can be converted back to glutamate via reverse glutamate 
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dehydrogenase consuming NADH. When all these contributions are taken into account we obtain a net pro-
duction of NADH coupled to the biosynthesis of precursor metabolites from glucose. The NADH produced can 
be oxidized in the mitochondria coupled to ATP generation. Assuming a 2.5 ATP/NADH yield we obtain that 
mammalian cells can produce bcoupled = 7.6 mol ATP/L coupled to NADH production by biosynthetic pathways 
(NADH OxPhos, Table 1).
The aerobic biosynthesis of a cell from glucose relies on the capacity of mitochondria to generate the energy 
required for biosynthesis and to oxidize the NADH generated through biosynthesis. In the following we calculate 
how fast a cell can proliferate given a specified mitochondrial content. If a is the growth-independent energy 
demand for cell maintenance, b is the OxPhos demand to duplicate the cell content, T is the cell doubling time, 
rM is the OxPhos capacity of mitochondria (mol ATP/L of mitochondria) and φM is the mitochondria volume 
fraction (L mitochondria/L cell) then the following constraint must be satisfied
φ+ ≤a b
T
rln2 (1)M M
If cells proliferate too fast, shortening the doubling time (left hand side of equation 1), they will overcome the 
maximum OxPhos capacity (right hand side of equation 1). From equation 1 we can determine the minimum 
doubling time that is supported by aerobic biosynthesis from glucose
Biomass component 
(% of dry weight)
Precursor demand 
(mol/L cell)
Energy demand bdemand 
(mol ATP/L cell)
NADH OxPhos bcoupled 
(mol ATP/L cell)
Protein 60 Amino acids 1.10 4.62 1.57
Lipids 16.7 AcCoA 1.19 1.04 5.95
Polysaccharides 6.7 Glucose 0.07 0.15 0
RNA 3.7 Ribonucl. 0.02 0.11 0.06
DNA 0.8 Deoxyribonucl. 0.01 0.03 0.01
Total 6.0 7.6
Table 1. Growth requirements. Composition and growth requirements of a typical mammalian cell. The 
NADH OxPhos column reports the energy that can be generated coupled to OxPhos of the NADH produced by 
biosynthetic pathways from glucose.
Figure 1. Biosynthesis from glucose. Synthesis of precursor metabolites from glucose. The text in italics 
represents the precursor requirements to duplicate a cell, using the one letter nomenclature for amino acids 
and x for AcCoA. Dehydrogenase steps are highlighted with red arrows (solid forward and dashed reverse) and 
transaminase steps with blue arrows. ATP and other cofactors have been omitted for simplicity.
www.nature.com/scientificreports/
3SCIentIfIC REPORTs | 7: 13488  | DOI:10.1038/s41598-017-14071-y
φ
=
−
T b
r a
ln2
(2)M M
min
The mitochondria OxPhos capacity (rM) has been measured for isolated mitochondria (Fig. 2 and 
Supplementary Table S2). It can be as high as 0.38 mol ATP/L mitochondria/min in muscle cells. The mitochon-
dria of yeast cells is as efficient, with rM = 0.29 mol ATP/L mitochondria/min. However, the mitochondria of 
cancer cells is 10 fold less efficient, wit rM = 0.042–0.068 mol ATP/L mitochondria/min.
Growth phases. As discussed above, even with mitochondria working at maximum capacity, a limited mito-
chondria content results in a limited oxidative phosphorylation capacity for both energy generation and NADH 
oxidation. What remains to be determined is whether such limitation is relevant when the actual mitochondria 
content and energy demand of cells are taken into consideration. To this end in Fig. 3 we depict the different 
scenarios that can occur depending on mitochondria content, maintenance energy and doubling time, as implied 
by equation (2). The top right corner corresponds with to a growth phase where cells can proliferate producing 
all the energy from OxPhos and can synthesize precursor metabolites from glucose (facultative OxPhos and 
facultative coupling of biosynthesis to NADH production, FF phase). We notice that “they can” does not imply 
“they must”. A cell line may have a doubling time and mitochondria content in that region, but it may have 
up-regulated aerobic glycolysis due to genetic alterations. Cells may also utilize alternative carbon sources due to 
overexpression of transport systems, reducing the NADH production coupled to biosynthesis. In such cases we 
can truly speak of an inefficient/wasteful/accidental phenotype. The other extreme is the grey zone highlighted 
in Fig. 3, where the energy demand associated with cell maintenance exceeds the OxPhos capacity (a > rMϕM in 
equation 2). In this region cells cannot survive without activating aerobic glycolysis.
In mammalian cells the energy that can be generated from OxPhos of the NADH produced in biosynthetic 
pathways exceeds the energy demand of biosynthesis (bdemand < bcoupled, Table 1). As cells decrease their doubling 
time and/or decrease their mitochondrial content, they will first be limited by the inability of mitochondria to 
turnover the NADH produced coupled to the biosynthesis of precursor metabolites (Fig. 3, red-dashed line). To 
proliferate faster, shortening the doubling time, mammalian cells need to uncouple NADH production from the 
synthesis of precursor metabolites (facultative OxPhos and obligatory uncoupling of biosynthesis from NADH 
production, FO phase). In the FO phase mammalian cells can satisfy their energy demand from OxPhos, until the 
energy demand of biosynthesis reaches the OxPhos capacity (Fig. 3, black-solid line). Below the black-solid line 
mammalian cells cannot satisfy their energy demand using OxPhos and they must switch on aerobic glycolysis 
(obligatory aerobic glycolysis and obligatory uncoupling of biosynthesis from NADH production, OO phase). In 
this case aerobic glycolysis is not an inefficient/wasteful/accidental phenotype, it is the only choice left to prolif-
erate faster.
To determine the location of cancer cells in the growth phase diagram of Fig. 3, we focus on the NCI60 panel 
of tumour derived cell lines. The doubling times for these cell lines has been reported by the NCI Developmental 
Therapeutics Program and we have estimated their mitochondrial content. Each cross in Fig. 3 represents a cell 
line in the NCI60 panel. Most cell lines fall in the grey area, where OxPhos cannot supply the energy requirements 
of cell maintenance and aerobic glycolysis must be activated. Indeed, these cell lines convert approximately 70% of 
Figure 2. Mitochondria capacity. Mitochondria intrinsic capacity (per volume of mitochondria) for ATP 
generation, based on data reported in the literature (Supplementary Table S2). Red represents data for different 
mammalian tissues and cell lines. Green represents data for yeast. As a reference, in dashed-blue we highlight 
the intrinsic capacity of glycolysis.
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the imported glucose to lactate21,22. For these cancer cells we can conclude that aerobic glycolysis is a consequence 
of a limited OxPhos capacity. Metabolic flux estimations indicate that these cells generate ATP from OxPhos in 
amounts comparable to aerobic glycolysis22. The observation of this mixed aerobic-glycolysis/OxPhos phenotype 
does not contradict our conclusion that aerobic glycolysis is obligatory for these cells. Simply the energy gener-
ated from OxPhos falls short of the energy demand.
Uncoupling NADH production from biosynthesis. Biosynthesis can be uncoupled from NADH 
generation in different ways. NADH can be turnover (NADH → NAD+) coupled to NADPH production 
(NADP+ → NADPH), using combinations of cytosolic/mitochondrial NAD+ and NADP+ dehydrogenases and 
the mitochondria transhydrogenase. We notice that the conversion of NADH to NADPH by the transhydroge-
nase transports protons from the mitochondria matrix to the cytosol, uncoupling OxPhos from ATP generation. 
Therefore, the NADH turnover by the transhydrogenase comes at expenses of exacerbating the limited OxPhos 
for energy production.
As an alternative, cells can switch to other carbon sources to reduce NADH production. The limited OxPhos 
capacity dictates which carbon sources are more suitable to uncouple NADH production from biosynthesis. 
Certainly for each amino acid the amino acid itself is a suitable alternative carbon source. The choice is in prin-
ciple more redundant for AcCoA (Fig. 4a). Acetate can be used with the extra cost of 1 ATP for the acetyl CoA 
ligase step. On the other hand, the β-oxidation of fatty acids generates NADH and FADH2 and therefore it does 
not reduce the NADH generation burden. AcCoA could also be produced from amino acids. However, in most 
cases NADH is generated (Fig. 4a, grey lines). The catabolism of isoleucine, leucine, lysine, methionine, trypto-
phan, and valine requires one or more dehydrogenase steps generating NADH. Alanine, cysteine, glycine, thre-
onine and serine can be converted to pyruvate, which still requires pyruvate dehydrogenase to produce AcCoa 
(Fig. 1). Aspartate and asparagine can be converted to oxaloacetate, which still requires a source of AcCoA for 
citrate synthesis or conversion to pyruvate, again requiring pyruvate dehydrogenase to produce AcCoa. Finally, 
arginine and proline can be converted to glutamate but NADH is generated in the process.
There are only two groups of amino acids that can be converted to citrate without NADH production. The 
first group includes glutamate and glutamine. Glutamate can be converted to citrate via reductive carboxylation. 
In this pathway the NAD(P)H production by glutamate dehydrogenase is compensated by the reverse activity 
of the NAD(P) isocitrate dehydrogenase (Fig. 1). Glutamate can be taken from the medium or generated from 
glutamine by glutaminase. Interestingly, arginine and proline can be produced from glutamate with concomitant 
consumption of NADH (Fig. 4a). This could provide an additional mechanism for NADH turnover. The sec-
ond group is composed of the amino acids phenylalanine and tyrosine, which are converted to acetoacetate and 
fumarate (Fig. 4a). Acetoacetate yields 2 AcCoa via the combined activity of acetoacetate CoA ligase (consuming 
one ATP) and acetyl-CoA transferase. Fumarate on the other hand is better excreted to avoid additional OxPhos 
burden. We notice that the catabolism of phenylalanine and tyrosine to acetoacetate consumes 3 and 2 oxygen 
molecules respectively. Therefore, these amino acids are not suitable to uncouple NADH production from bio-
synthesis under hypoxia.
Figure 3. Growth phase diagram. Different growth phases as a function of the cell doubling time and 
mitochondrial content. The black-solid line is obtained using equation 2, setting the OxPhos demand equal to 
the energy demand of cell duplication (b = bdemand). The red dashed line is obtained using equation 2, setting the 
OxPhos demand equal to the NADH OxPhos of cell duplication (b = bcoupled). The grey area demarks the region 
where the OxPhos capacity is insufficient to satisfy the energy demand for cell maintenance, with solid and 
dashed patterns indicating the certain area average minus one standard deviation and uncertain are (average 
plus minus two standard deviations) given our current estimates of the cell maintenance. The plusses represent 
60 cancer cell lines from the NCI60 panel.
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NADPH production. For the sake of simplicity we have omitted the balance of some key co-factors that are 
also required for cell proliferation. NADPH is a free energy source required in the biosynthesis of some amino 
acids and of lipids. The pentose phosphate pathway (PPP) is a major source of NADPH production. The PPP 
is interconnected with the upper part of glycolysis, above the glyceraldehyde 3-phosphate dehydrogenase step. 
Therefore, the PPP does not change the pyruvate/NADH yield ratio of glycolysis, which is the only feature of 
glycolysis used to calculate the biosynthetic requirements reported in Table 1. The increase in the NADPH yield 
just reduces the percentage of glucose carbons incorporated into biomass (1 CO2 molecule is released per every 
2 NADPH).
NADPH can also be produced via one-carbon metabolism using serine as the one-carbon source23,24. The 
synthesis of serine from glucose generates NADH (Fig. 1). Therefore the glucose → serine → one-carbon pathway 
of NADPH generation is only suitable when cells have not reached their maximum OxPhos capacity. When cells 
have overcome their OxPhos capacity they could import serine from the media to uncouple NADH production 
from NADPH production via one-carbon metabolism. To donate the one-carbon unit serine is converted to gly-
cine and glycine could also donate a one-carbon unit via the glycine cleavage system. The glycine cleavage system 
generates NADH and therefore this pathway is only suitable when cells have not reached their maximum OxPhos 
capacity. Otherwise, glycine is better excreted to avoid additional NADH production.
Discussion
When the metabolic demand exceeds the limited OxPhos capacity mammalian cells split their metabolism into 
two major components (Fig. 4b). There is a component of high NADH flux from aerobic glycolysis (Fig. 4b, black 
background box). The function of this component is to satisfy the energy demand beyond the OxPhos capacity. 
Figure 4. Metabolism under a limited OxPhos capacity. (a) Synthesis of AcCoA from alternative carbon 
sources. In grey we highlight carbon sources that result in NADH production. The boxes highlight the carbon 
sources that uncouple AcCoA synthesis from NADH production. (b) Compartmentalization of eukaryote 
aerobic cell metabolism in the context of a limited OxPhos capacity.
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There is another component of low NADH flux where precursor metabolites are produced from glucose and 
other carbon sources (Fig. 4b, white background box). The function of this component is to generate precursor 
metabolites with the minimal NADH generation that can be absorbed by the limited OxpHos capacity. The choice 
of alternative carbon sources is restricted to those that do not generate NADH in their conversion to precursor 
metabolites. For generation of AcCoA, this constraint leave cells with the choice of acetate and the amino acids 
glutamate, glutamine, phenylalanine and tyrosine.
In the context of cancer metabolism it has been often claimed that aerobic glycolysis is a consequence of an 
increased demand of carbon atoms for biosynthesis of precursor metabolites25,26. A more precise statement is 
that the increased demand for carbon atoms results in an increased demand for NADH turnover when glucose 
is the carbon source. However, the excretion of lactate does not solve the problem of NADH production coupled 
to biosynthesis. While it is true that lactate dehydrogenase converts NADH back to NAD+, the carbon atoms 
associated with this conversion are excreted as lactate and they do not contribute to the formation of biomass 
precursors. We conclude, as originally postulated by Warburg and supported by previous calculations27, that the 
role of aerobic glycolysis is to satisfy the energy demand in the context of limited mitochondria OxPhos capacity.
These conclusions will hold up to small variations in the parameter values required for the analysis. 
Imprecisions in the demand of energy and NADH turnover may cause a change in the order of the continuous 
and dashed lines in Fig. 3, but the two phases at the top-right and bottom-left corners will remain. The intrinsic 
mitochondria efficiency of cancer cells may be larger than the values obtained for PC-3 and HeLa cells, causing 
some cell lines to fall in the growth phase where aerobic glycolysis is not obligatory. Therefore, our conclusion of 
aerobic glycolysis being obligatory may not necessarily hold for all cancer cells. In spite of these potential issues, 
this analysis provides a conceptual framework that brings together apparently disconnected metabolic pheno-
types of cancer cells.
Methods
Cell composition. The typical biomass composition of mammalian cells was obtained from ref.28. The typical 
composition in terms of precursor metabolites (mol of precursor/L cell) was calculated using the equation
π
μ
=c
v (3)s cell,
where π is the dry weight fraction of the biomass component, μ is the molecular weight of the precursor metab-
olite and vs,cell is the cell specific volume (L cell/g dry weight). Amino acids are the precursor metabolites of 
proteins. The average molecular weight of an amino acid in expressed proteins is μaa = 109 g/mol in mammalian 
cells29. The acetyl group of AcCoA is the precursor of lipids. Its average molecular weight in lipids was estimated 
as two times the molecular weight of CH2 (μac = 28 g/mol). Ribonucleotides are the precursor metabolites of 
RNA. The average molecular weight of a ribonucleotide in expressed RNAs is μrn = 331 g/mol in mammalian 
cells29. Deoxyribonucleotides are the precursor metabolites of DNA. The average molecular weight of a deoxyri-
bonucleotide in expressed DNA is μdn = 332 g/mol in mammalian cells29. Finally, the cell specific volume is 5 mL/
gDW for mammalian cells30.
Energy requirements of biosynthesis. The mammalian cell energy requirement for synthesis of each 
biomass component from glucose was estimated as the number of ATP molecules required to synthesize the pre-
cursor from glucose, based on reported biosynthesis pathways31, plus the energy required for polymerization29, 
times the precursor concentration (Supplementary Table S1).
NADH OxPhos. The number of NADH molecules produced coupled to the synthesis of each precursor 
metabolite from glucose was calculated from reported biosynthesis pathways31. This value was multiplied by a 
yield of 2.5 ATP/NADH times the precursor concentration reported in Table 1 (see also Supplementary Table S1).
Mitochondria OxPhos capacity. The mitochondria OxPhos capacity rM was obtained from literature 
reports (Supplementary Table S2).
Maintenance energy. We have estimated the cell maintenance energy of cancer cells using literature reports 
of extracellular acidification rates (ECAR) and oxygen consumption rates (OCR) quantified using the Seahorse 
instrument (Table S3). The ECAR and OCR measurements where then converted to energy production from gly-
colysis and OxPhos using the protocol reported in reference {Mookerjee, 2017 #7479}. The energy maintenance 
was estimated as the total energy production (glycolysis + OxpHos) minus the energy requirements of growth 
(6 mol ATP/L cell × ln2/Td). The average and standard deviation across cell lines was used to calculate the shadow 
areas in Fig. 3. The average value across cell lines was 5 mmol ATP/L cell/min, no far from an estimated based 
on data reported for the LS mouse cell line32. LS mouse cells require 17 pmol ATP/cell/day for cell maintenance. 
Dividing by the LS cell volume (3.4 pL/cell) we obtain the cell maintenance energy demand per cell volume 
amammalian = 3.5 mmol ATP/L cell/min.
NCI60. The doubling times for each cell line are reported by the NCI Developmental Therapeutics Program 
https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm. Their mitochondrial content was estimated as
P
V
v
p l
p (4)
M
cell
cell
s mitochondria
i i i
i i
,φ =
∑
∑
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where Pcell is the protein content (g/cell), Vcell is the cell volume (L/cell), vs,mitochondria is the mitochondrial specific 
volume (L/g mitochondrial protein), the sums run over all expressed proteins, pi is the abundance of each protein 
and li = 1 if the protein localizes to the mitochondria and 0 otherwise. Pcell and Vcell are reported in ref.22. The 
mitochondria specific volume is vs,mitochondria = 2.6 mL/g mitochondrial protein33. The relative protein abundances 
where obtained from reported proteomic data34. The protein localization we obtained from the NCBI annota-
tions. li was set to 1 for every protein that is annotated to localize to the mitochondria. The estimated mitochon-
dria content is reported in the Supplementary Table S4.
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